Abstract
Background Isolated REM sleep behavior disorder (iRBD) is the most specific prodromal marker of Parkinson’s disease (PD), often accompanied by various non-motor symptoms. In PD, non-motor symptoms are strongly associated with reduced health-related quality of life (hrQoL).
Objectives To identify factors linked to poorer hrQoL in patients with iRBD and to compare their hrQoL to healthy control participants (HC) and patients with PD.
Methods Sixty-two patients with iRBD (M = 66.44±6.14), 29 patients with PD (M = 67.21±7.23), and 19 HC (M = 67.57±8.16) were included. We administered the 36-Item Short Form Health Survey (SF-36) to assess hrQoL. Additionally, participants underwent a comprehensive clinical evaluation of non-motor symptoms.
Results The SF-36 total score was significantly lower in patients with iRBD (83.33±16.96) compared to HC (92.29±5.49, U = 390.00, Z = −2.218, p = .027, r = 0.246). Poorer hrQoL in patients with iRBD was linked to self-reported neuropsychiatric symptoms, sleep-wake disturbances, and a higher burden of autonomic symptoms (all r = -.25 to -.76, all p < .05). Multiple regression analysis revealed fatigue and depressive symptoms as significant predictors of poorer hrQoL in patients with iRBD (F (5.56) = 51.59, p < .001, adjusted R2 = 0.81).
Conclusions This study highlights the importance of non-motor symptoms for hrQoL in prodromal PD, irrespective of motor symptoms. Fatigue and depressive symptoms arise as the most relevant therapeutic targets in the prodromal stage of PD to optimize the patient’s quality of life.
Competing Interest Statement
S.R., M.-S.L., A.S., J.K., and K.-L.W. report no disclosures. C.E.J.D. is supported by the Clinician Scientist Program (CCSP), funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation, FI 773/15-1). G.R.F. receives royalties from the publication of the books Funktionelle MRT in Psychiatrie und Neurologie, Neurologische Differentialdiagnose, and SOP Neurologie and received honoraria for speaking engagements from Forum fuer medizinische Fortbildung FomF GmbH as well as grants from Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), Project-ID 431549029, SFB 1451. A.O. received a grant from the Koeln Fortune Program (grant-no. 329/2021), Faculty of Medicine, University of Cologne, and the ″Novartis-Stiftung fuer therapeutische Forschung″, both outside the submitted work. M.S. received grants from the Else Kroener-Fresenius-Stiftung (grant number 2019_EKES.02), and the Koeln Fortune Program, Faculty of Medicine, University of Cologne. M.S. receives additional funding from the program ″Netzwerke 2021″, an initiative of the Ministry of Culture and Science of the State of Northrhine Westphalia. The sole responsibility for the content of this publication lies with the authors.
Funding Statement
S.R., M.-S.L., A.S., J.K. and K.-L.W. report no disclosures. C.E.J.D. received grants from the Clinician Scientist Program (CCSP), funded by the German Research Foundation (DFG, FI 773/15-1). G.R.F. receives royalties from the publication of the books Funktionelle MRT in Psychiatrie und Neurologie, Neurologische Differentialdiagnose, and SOP Neurologie and received honoraria for speaking engagements from Forum fuer medizinische Fortbildung FomF GmbH as well as grants from Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), Project-ID 431549029, SFB 1451. A.O. received a grant from the Koeln Fortune Program (grant-no. 329/2021), Faculty of Medicine, University of Cologne, and the ″Novartis-Stiftung fuer therapeutische Forschung″, both outside the submitted work. M.S. received grants from the Else Kroener-Fresenius-Stiftung (grant number 2019_EKES.02), and the Koeln Fortune Program, Faculty of Medicine, University of Cologne. M.S. receives funding from the program ″Netzwerke 2021″, an initiative of the Ministry of Culture and Science of the State of Northrhine Westphalia. The sole responsibility for the content of this publication lies with the authors.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethics committee of the Medical Faculty of the University of Cologne gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
